| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |